恒道医药 (873870.OC)

+ 收藏

利润表(恒道医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市前
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 85,128,482.40158,712,210.5172,327,227.6560,092,070.2948,938,713.10
 营业收入(元) 85,128,482.40158,712,210.5172,327,227.6560,092,070.2948,938,713.10
二、营业总成本(元) 52,098,606.1795,657,497.6139,681,869.1749,120,506.0717,992,120.02
 营业成本(元) 33,779,311.3262,875,514.1925,775,895.9418,175,297.906,357,599.51
 研发费用(元) 10,505,209.4516,989,955.766,641,565.7017,770,779.557,157,667.66
 营业税金及附加(元) 516,874.41596,099.04234,854.22444,626.93191,917.93
 销售费用(元) 879,745.822,347,376.481,056,988.521,852,470.45561,514.39
 管理费用(元) 7,020,942.8613,176,203.845,906,664.4610,565,014.843,610,858.44
 财务费用(元) -603,477.69-327,651.7065,900.33312,316.40112,562.09
  其中:利息费用(元) 681.66112,827.3480,064.80392,025.71138,381.69
  其中:利息收入(元) 604,987.34445,341.2517,518.6885,759.9730,165.55
三、其他经营收益
 加:公允价值变动收益(元) 1,474,636.411,913,315.93-280,851.54-
 加:投资收益(元) 1,308,311.24-3,790,109.89-1,929,579.29-1,980,262.751,206,651.55
  其中:对联营企业和合营企业的投资收益(元) -956,064.00--2,219,096.86--
 资产处置收益(元) 53,601.58117,808.82---
 资产减值损失(元) 203,545.99-596,891.7054,117.76-98,275.14-385,781.57
 信用减值损失(元) -106,258.93-619,966.78-308,894.5076,812.90361,093.32
 其他收益(元) 58,795.54956,186.7689,242.912,680,766.841,640,866.84
四、营业利润(元) 36,022,508.0661,035,056.0430,550,245.3611,931,457.6133,769,423.22
 加:营业外收入(元) 409.373,327.321,764.2113,680.1211,020.12
 减:营业外支出(元) 8,214.5071,850.1819,492.57397,963.38113,163.20
五、利润总额(元) 36,014,702.9360,966,533.1830,532,517.0011,547,174.3533,667,280.14
 减:所得税费用(元) 3,875,840.647,401,128.661,515,904.15309,665.265,116,627.26
六、净利润(元) 32,138,862.2953,565,404.5229,016,612.8511,237,509.0928,550,652.88
(一)按经营持续性分类
  持续经营净利润(元) 32,138,862.2953,565,404.5229,016,612.8511,237,509.0928,550,652.88
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 32,138,862.2953,565,404.5229,016,612.8511,237,509.0928,550,652.88
 扣除非经常性损益后的净利润(元) 28,858,375.2750,691,915.4928,709,735.5537,296,054.09-
七、每股收益
 一、基本每股收益(元) 1.202.321.300.521.35
 二、稀释每股收益(元) 1.202.321.300.521.35
八、其他综合收益(元) -795,107.34-1,626,203.16--1,293,490.96-
 归属于母公司股东的其他综合收益(元) -795,107.34-1,626,203.16--1,293,490.96-
九、综合收益总额(元) 31,343,754.9551,939,201.3629,016,612.859,944,018.1328,550,652.88
 归属于母公司所有者的综合收益总额(元) 31,343,754.9551,939,201.3629,016,612.859,944,018.1328,550,652.88
公告日期 2024-08-272024-04-262023-08-252023-04-242023-08-25
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院